Sight-saving diabetes drug gets NICE approval

Patients with diabetic macular edema were dealt a blow in Nov 2011 when health watchdog NICE refused to make Lucentis available on the NHS on the grounds is was too expensive. However, the drug, which costs about £750 per injection has been approved for specific cases. NICE said fresh analysis showed it had a superior relative effect in some patients.



Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).
Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags